Selective cyclooxygenase 2 inhibition lowers spinal cord prostaglandin concentrations after injury

Spine Journal

Volumn 1, Issue 6, 2001, Pages 437-441

  Resnick, Daniel K ^a   Nguyen, Peter ^a   Cechvala, Catherine F ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Arachadonic acid; Cyclooxygenase; Prostaglandin; Spinal cord injury; Thromboxane

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ISOENZYME; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; THROMBOXANE B2;

ANIMAL; ARTICLE; DISEASE MODEL; DRUG ANTAGONISM; LONG EVANS RAT; MALE; METABOLISM; RAT; SPINAL CORD; SPINAL CORD INJURY;

ANIMALS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DISEASE MODELS, ANIMAL; ISOENZYMES; MALE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, LONG-EVANS; SPINAL CORD; SPINAL CORD INJURIES; THROMBOXANE B2;

EID: 0035851771     PISSN: 15299430     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1529-9430(01)00117-6     Document Type: Article

References (24)

1. Bracken M., Shepard M., Collins W.et al. Administration of methylprednisolone for 24 or 48 hours or tirilizad methsylate for 48 hours in the treatment of acute spinal cord injury. Results of the third national acute spinal cord injury randomized controlled trial. J Am Med Assoc. 277:1977;1597-1604.
2. Hay C.H., de Belleroche J.S. Dexamethasone prevents the induction of COX-2 mRNA and prostaglandins in the lumbar spinal cord following intraplantar FCA in parallel with inhibition of oedema. Neuropharmacology. 37:1998;739-744.
3. Resnick D.K., Graham S., Dixon C., Marion D. Role of cyclooxygenase 2 in acute spinal cord injury. J Neurotrauma. 15:1998;1005-1013.
4. Seibert K., Zhang Y., Leahy K.et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci USA. 91:1994;12013-12017.
5. Gruner J. A monitored contusion model of spinal cord injury in the rat. J Neurotrauma. 9:1992;123-128.
6. Hall E., Wolf D., Braughler J. Effects of a single large dose of methylprednisolone sodium succinate on experimental posttraumatic spinal cord ischemia. J Neurosurg. 61:1984;124-130.
7. Means E., Anderson D., Waters T., Kalaf L. Effect of methylprednisolone in compression trauma to the feline spinal cord. J Neurosurg. 55:1981;200-208.
8. Young W., Flamm E. Effect of high dose corticosteroid therapy on blood flow, evoked potentials, and extracellular calcium in experimental spinal injury. J Neurosurg. 57:1982;667-673.
9. Hall E., Yonkers P., Andrus P., Cox J., Anderson D. Biochemistry and pharmacology of lipid antioxidants in acute brain and spinal cord injury. J Neurotrauma. 9:1992;S425-S442.
10. Yamagata K., Andreasson K., Kaufmann W., Barnes C., Worley P. Expression of a mitogen inducible cyclooxygenase in brain neurons. regulation by synaptic activity and glucocorticoids Neuron. 11:1993;371-386.
11. Liu D., Li L., Augustus L. Prostaglandin release by spinal cord injury mediates production of hydroxyl radical, malondialdehyde and cell death. a site of the neuroprotective action of methylprednisolone J Neurochem. 97:2001;1036-1047.
12. Mitsuhashi T., Ikata T., Morimoto K., Tonai T., Katoh S. Increased production of eicosanoids, TXA2, PGI2, LTC4 in experimental spinal cord injuries. Paraplegia. 32:1994;524-530.
13. Hsu C., Halushka P., Hogan E., Cox R. Increased thromboxane level in experimental spinal cord injury. J Neurol Sci. 74:1986;289-296.
14. Hsu C., Halushka P., Hogan E., Banik N., Lee W., Perot P. Ateration of thromboxane and prostacyclin levels in experimental spinal cord injury. Neurology. 35:1985;1003-1009.
15. Akpek E., Bulutcu E., Alanay A.et al. A study of adenosine treatment in experimental acute spinal cord injury. Spine. 24:1999;128-132.
16. Nishisho T., Tonai T., Tamura Y., Ikata T. Experimental and clinical studies of eicosanoids in cerebrospinal fluid after spinal cord injury. Neurosurgery. 39:1996;950-957.
17. Hall E., Yonkers P., Taylor B., Sun F. Lack of effect of postinjury treatment with methylprednisolone or tirilizad mesylate on the increase in eicosanoid levels in the acutely injured cat spinal cord. J Neuro-trauma. 12:1995;245-256.
18. Sharma H., Olsson Y., Cervos-Navarro J. Early perifocal cell changes and edema in traumatic injury of the spinal cord are reduced by indomethacin, an inhibitor of prostaglandin synthesis. Acta Neuropathol. 85:1993;145-153.
19. Sharma H.S., Olsson Y., Nyberg F., Dey P.K. Prostaglandins modulate alterations of microvascular permeability, blood flow, edema and serotonin levels following spinal cord injury. an experimental study in the rat Neuroscience. 57:1993;443-449.
20. Guth L., Zhang Z., DiProspero N., Joubin K., Fitch M. Spinal cord injury in the rat. treatment with bacterial lipopolysaccharide and indomethacin enhances cellular repair and locomotor function Exper Neurol. 126:1994;76-87.
21. Guth L., Zhang Z., Roberts E. Key role for pregnenolone in combination therapy that promotes recovery after spinal cord injury. Proc Nat Acad Sci USA. 91:1994;12308-12312.
22. Nogawa S., Zhang F., Ross M., Iadecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci. 17:1997;2746-2755.
23. Nakayama M., Uchimura K., Zhu R.et al. Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proc Nat Acad Sci USA. 95:1998;10954-10959.
24. Resnick DK, Nguyen P, Cechvala C. Perfusion of animals following spinal cord injury reduces intra-group variance in measured prostaglandin levels. AANS Joint Section on Disorders of the Spine and Peripheral Nerves, February 2001.